Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy of gastrointestinal cancer.

× No keyword cloud information.

48 in total

Review 1. Current and emerging treatments for pancreatic cancer.

Authors: W F Regine; W J John; M Mohiuddin
Journal: Drugs Aging Date: 1997-10 Impact factor: 3.923

2. Carcinoid tumors of the thymus.

Authors: S Venkatesh; N A Samaan
Journal: West J Med Date: 1990-01

3. An evaluation of combination 5-fluorouracil and spirogermanium in the treatment of advanced colorectal carcinoma.

Authors: M L McMaster; F A Greco; D H Johnson; J D Hainsworth
Journal: Invest New Drugs Date: 1990-02 Impact factor: 3.850

4. Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinoma.

Authors: N J Petrelli; S Madejewicz; Y Rustum; L Herrera; P J Creaven; J Plager; J Soloman; A Mittelman
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

Review 5. Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.

Authors: Andrea Teague; Kian-Huat Lim; Andrea Wang-Gillam
Journal: Ther Adv Med Oncol Date: 2015-03 Impact factor: 8.168

6. Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors.

Authors: A Y Bedikian; M Valdivieso; G P Bodey; E J Freireich
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

7. 5-Fluorouracil (5FU) with or without folinic acid (LV) in human colorectal cancer? Multivariate meta-analysis of the literature.

Authors: D Brohée
Journal: Med Oncol Tumor Pharmacother Date: 1991

Review 8. Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapy.

Authors: P J Houghton; J A Houghton; B J Hazelton; S Radparvar
Journal: Invest New Drugs Date: 1989-04 Impact factor: 3.850

9. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.

Authors: H Bismuth; R Adam; F Lévi; C Farabos; F Waechter; D Castaing; P Majno; L Engerran
Journal: Ann Surg Date: 1996-10 Impact factor: 12.969

10. Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancer.

Authors: P I Clark; M L Slevin; R H Reznek; N Niederle; E Kurschel; G Lundell; B Cedermark; A Fallenius; H Blomgren; U Ohman
Journal: Int J Colorectal Dis Date: 1987-02 Impact factor: 2.571